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ABSTRACT
Background Studies suggest that certain black and Asian 
minority ethnic groups experience poorer outcomes from 
COVID-19, but these studies have not provided insight into 
potential reasons for this. We hypothesised that outcomes 
would be poorer for those of South Asian ethnicity hospitalised 
from a confirmed SARS- CoV-2 infection, once confounding 
factors, health- seeking behaviours and community 
demographics were considered, and that this might reflect a 
more aggressive disease course in these patients.
Methods Patients with confirmed SARS- CoV-2 infection 
requiring admission to University Hospitals Birmingham 
NHS Foundation Trust (UHB) in Birmingham, UK between 10 
March 2020 and 17 April 2020 were included. Standardised 
admission ratio (SAR) and standardised mortality ratio (SMR) 
were calculated using observed COVID-19 admissions/
deaths and 2011 census data. Adjusted HR for mortality was 
estimated using Cox proportional hazard model adjusting and 
propensity score matching.
Results All patients admitted to UHB with COVID-19 
during the study period were included (2217 in total). 58% 
were male, 69.5% were white and the majority (80.2%) 
had comorbidities. 18.5% were of South Asian ethnicity, 
and these patients were more likely to be younger and 
have no comorbidities, but twice the prevalence of 
diabetes than white patients. SAR and SMR suggested 
more admissions and deaths in South Asian patients than 
would be predicted and they were more likely to present 
with severe disease despite no delay in presentation since 
symptom onset. South Asian ethnicity was associated with 
an increased risk of death, both by Cox regression (HR 1.4, 
95% CI 1.2 to 1.8), after adjusting for age, sex, deprivation 
and comorbidities, and by propensity score matching, 
matching for the same factors but categorising ethnicity 
into South Asian or not (HR 1.3, 95% CI 1.0 to 1.6).
Conclusions Those of South Asian ethnicity appear at 
risk of worse COVID-19 outcomes. Further studies need to 
establish the underlying mechanistic pathways.
TINTRODUCTION
COVID-19 was identified in January 20201 
and given its designated name by the WHO 
in February 2020.2 Initial reports from China, 
Italy and the USA focused on risk factors 
which predisposed individuals to severe 
manifestations of infection such as viral 
pneumonia and adult respiratory distress 
syndrome (ARDS) requiring critical care 
support and death, including age, male sex 
and comorbidities.3–6
A more recent report from the Centers for 
Disease Control and Prevention in the USA 
described an early sign of non- Hispanic, black 
people being disproportionally affected by 
COVID-19 hospitalisation.7 In the UK, Inten-
sive Care National Audit and Research Centre 
reports8 9 described that a higher propor-
tion of patients requiring critical care for 
COVID-19 were of Asian and black ethnicity 
compared with pre- COVID-19 historical data 
(2017–2019) for patients who required crit-
ical care for viral pneumonia. Since then, two 
studies, one from Office for National Statis-
tics analysing over 10 000 deaths in UK10 and 
Key messages
 ► There were more admissions from South Asian pa-
tients to our hospital than would be expected based 
on our local population.
 ► These patients were admitted with a worse sever-
ity of COVID-19- related respiratory compromise 
without a significant delay in presentation and ex-
perience a higher level of mortality even when differ-
ences in age, sex, deprivation and key comorbidities 
were taken into account.
 ► South Asian ethnicity may form another ‘at risk’ 
population from COVID-19, and further studies are 
needed to identify any treatable factors to improve 
outcomes as well as to refine our understanding and 
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another examining around 5000 deaths from primary 
care records,11 concluded twofold to threefold high 
death rates in ethnic minority groups after accounting for 
important confounders. However, both studies reported 
mortality at a population level that could be a reflection 
of higher infection rates in these ethnic groups rather 
than a higher case fatality rate.
The West Midlands is experiencing a high incidence of 
COVID-19- associated hospitalisations. This is particularly 
marked in Birmingham, which has a higher than average 
percentage of minority ethnic groups, with the 2011 
census reporting the following percentages: South Asian 
23.4%, black 7.8%, mixed ethnicity 4.1%, others 1.8% 
and a lower than average white ethnic group at 63%.12
University Hospitals Birmingham NHS Foundation 
Trust (UHB) is one of the largest National Health Service 
(NHS) Trusts in England, providing direct acute services 
and specialist care across four hospital sites, including 
2.2 million patient episodes per year, with 2750 beds 
and an expanded ITU capacity of up to 250 beds during 
the COVID-19 pandemic. UHB constitutes four acute 
hospital sites following organisational merger in 2018. 
At present the Queen Elizabeth Hospital Birmingham 
(QEHB) runs a fully electronic healthcare record (EHR) 
(PICS; Birmingham Systems, in place since 1999), while 
the other three sites currently run mixed electronic and 
paper healthcare records and a shared primary and 
secondary care record (Your Care Connected). UHB 
provides secondary care to a diverse population of 1.3 
million in Birmingham and Solihull and provides a full 
range of tertiary services to the West Midlands region.
It was hypothesised that South Asian ethnicity would 
form a risk factor for the most severe respiratory mani-
festations of COVID-19 infection, even once age, sex, 
medical conditions and social deprivation were taken 
into account, and therefore:
 ► They have more admissions than would be expected 
given the proportion of different ethnic groups within 
the Birmingham Trust catchment area (based on the 
last census data).
 ► They have worse outcomes (death and/or admis-
sion to critical care) from hospitalised COVID-19 
viral infection than white ethnic group, even once 
age, gender, deprivation and comorbidities were 
accounted for.
 ► They have more severe disease on presentation based 
on a severity score which could not be explained by 
duration of symptoms, compared with non- South 
Asian patients.
The study had the following aims:
 ► To identify all COVID-19 confirmed patients admitted 
to UHB hospital within a determined timeframe.
 ► To determine the expected and observed admission 
and death rates given the local population.
 ► To determine whether South Asian ethnicity was asso-
ciated with poor outcomes following hospitalisation 
with confirmed COVID-19 infection, once potentially 
confounding factors were considered.
 ► To explore if disease presentation was more severe in 
patients of South Asian ethnicity and if there was any 
evidence of a delayed presentation to hospital.
METHODS
This retrospective cohort study, using prospectively 
collected data, was conducted in affiliation with 
PIONEER, the UK Health Data Research Hub in acute 
care.
Study population
All patients with a confirmed positive SARS- CoV-2 swab 
result between 09:00 on 10 March 2020 and 16:00 on 17 
April 2020 and who were admitted to UHB at the time of 
or up to 2 weeks following their first positive SARS- CoV-2 
swab test were included. COVID-19 cases were confirmed 
following a nasopharyngeal and oropharyngeal swab in 
all cases,13 which were processed in accordance with NHS 
guidance within UHB NHS laboratories.14 Mortality and 
(in those alive) patient admission status (discharged and 
alive, continued admission and alive) were assessed on 12 
May 2020.
Data collection and variable definitions
Patient demographics and clinical data were collected 
from the EHR and from mandatory data sets within the 
Trust. Clinician- confirmed comorbidities were available 
from the EHR, the depth of which was enhanced by access 
to a summary primary care record (Your Care Connected) 
and further enriched with diagnostic codes derived from 
previous hospital episodes. The EHR encodes diagnoses 
using NHS Digital SNOMED CT browser15 alongside 
and mapped on to the International Classification of 
Diseases (ICD)-10 codes,16 allowing for the presenta-
tion and inclusion of historically entered ICD-10 codes. 
Comorbidities of interest were defined by those associ-
ated with poor outcomes from previous publications17 18 
in order to determine the impact of multimorbidity.18 
The most common clusters of diagnostic categories are 
listed in table 1. A simple count of comorbidities was 
undertaken to determine the impact of multimorbidity, 
as described.18 English Indices of Deprivation scores 
were calculated using postcodes from the current data 
provided by the UK’s Ministry of Housing, Communities 
and Local Government (2019) report.19 Seven main types 
of deprivation are considered in the Index of Multiple 
Deprivation 2019—income, employment, education, 
health, crime, access to housing and services, and living 
environment—and these are combined to form the 
overall measure of multiple deprivation.
Ethnicity was self- reported by the patient or their 
family members on admission to hospital. Where these 
data were missing, it was gathered from previous admis-
sions and by reviewing primary and secondary medical 
records. If this was not available (as was the case in 91 
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n 2217 1540 410 134
Age in years, median (IQR) 73 (58–84) 77 (66–86) 61 (45–73) 62 (53–79)
Sex, n (%)
  Female 927 (41.8) 639 (41.5) 170 (41.5) 59 (44.0)
  Male 1290 (58.2) 901 (58.5) 240 (58.5) 75 (56.0)
Self- reported ethnicity, n (%) N/A N/A N/A
  White 1540 (69.5)
  Mixed/multiple 18 (0.8)
  South Asian/South Asian British 410 (18.5)
  Black/African/Caribbean/black British 134 (6.0)
  Other ethnic group 67 (3.0)
  Preferred not to say 22 (1.0)
  Not known 26 (1.2)
Comorbidity count, n (%)
  None 439 (19.8) 255 (16.6) 114 (27.8) 25 (18.7)
  1–2 888 (40.1) 620 (40.3) 155 (37.8) 61 (45.5)
  3 or more 890 (40.1) 665 (43.2) 141 (34.4) 48 (35.8)
Morbidities, n (%)
  Hypertension 864 (39.0) 649 (42.1) 126 (30.7) 50 (37.3)
  Cerebrovascular disease 268 (12.1) 233 (15.1) 18 (4.4) 10 (7.5)
  Atrial fibrillation 464 (20.9) 404 (26.2) 26 (6.3) 20 (14.9)
  Ischaemic heart disease, angina, myocardial 
infarct
546 (24.6) 404 (26.2) 100 (24.4) 24 (17.9)
  Diabetes (type 1 and 2) 752 (33.9) 434 (28.2) 197 (48.0) 72 (53.7)
  Asthma 439 (19.8) 290 (18.8) 91 (22.2) 34 (25.4)
  COPD 376 (17.0) 333 (21.6) 20 (4.9) 14 (10.5)
  Interstitial lung disease 49 (2.2) 40 (2.6) 4 (1.0) 2 (1.5)
  Chronic kidney disease 511 (23.0) 338 (21.9) 111 (27.1) 42 (31.3)
  Any active malignancy 152 (6.9) 124 (8.1) 12 (2.9) 7 (5.2)
  Dementia (all types) 326 (14.7) 283 (18.4) 22 (5.4) 10 (7.5)
  Obesity 267 (12.0) 174 (11.3) 60 (14.6) 12 (9.0)
English Indices of Deprivation, n (%)
  1 (most deprived) 1003 (45.2) 554 (36.0) 276 (67.3) 89 (66.4)
  2 416 (18.8) 320 (20.8) 50 (12.2) 26 (19.4)
  3 311 (14.1) 263 (17.1) 29 (7.1) 11 (8.2)
  4 230 (10.3) 195 (12.7) 18 (4.4) 4 (3.0)
  5 (least deprived) 225 (10.1) 195 (12.7) 20 (4.9) 3 (2.2)
Missing, n (%) 32 (1.4) 13 (0.8) 17 (4.2) 1 (0.8)
Recovered and discharged, n (%) 1052 (47.5) 679 (44.1) 225 (54.9) 76 (56.7)
Remain admitted at point of data census, n (%) 554 (25.0) 411 (26.7) 79 (19.3) 26 (19.4)
Died, n (%) 611 (27.5) 450 (29.2) 106 (25.9) 32 (23.9)
Duration of symptoms prior to admission (in days), n 
where data were available (% of 567)
567 350 (61.7) 123 (21.7) 37 (6.5)
Median (IQR) 7 (3–10) 6 (3–10) 7 (4–10) 7 (3.5–13.5)
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of patients with the same surname in the EHR database 
where possible, as previously described,20 but remained 
unavailable in 48 patients (see table 1 for missing data). 
Ethnicity was grouped as per national guidelines.21
Severity of COVID-19 on admission
Physician- determined severity of COVID-19 on first 
admission was categorised using a pragmatic and locally 
developed score which made use of baseline physiolog-
ical assessments and oxygen requirements to identify 
those on admission to hospital who were in need of 
urgent critical care assessments for respiratory support, 
and is as follows:
 ► Patients were considered to have severe respiratory 
manifestations of COVID-19 infection if COVID-19 
was suspected and the patient required inspired 
oxygen ≥50% to maintain targeted oxygen satu-
rations (>93% except in the presence of type 2 
respiratory failure where the target saturations were 
88%–92%) with respiratory pathology thought driven 
by COVID-19 illness.
 ► If not severe, patients were considered to have 
moderate severity respiratory manifestations of 
COVID-19 infection if COVID-19 was suspected and 
the patient required inspired oxygen of >4 L/min 
or inspired oxygen >28% to maintain target oxygen 
saturations.
 ► Patients were considered to have mild severity respira-
tory manifestations of COVID-19 infection if the 
patient had respiratory symptoms but did not meet 
the severe or moderate criteria as described above.
Baseline physiological assessments to determine severity 
of COVID-19 were considered to be those taken within 24 
hours either side of the SARS- CoV-2 swab collection time, 
of which the earliest available measurement was used. 
Since not all patients were admitted within 24 hours of 
their SARS- CoV-2 swab test, and since these assessments 
are only routinely recorded in the EHR system for QEHB 
patients, baseline severity scores were only available for a 
subset of patients (736 of 2217).
To determine if disease severity on admission reflected 
duration of illness, medical clerking notes were reviewed 
to determine the duration of symptoms prior to admis-
sion. This was available in only a subset of patients (567 
of 2217).
Outcomes
The primary outcome was death while in hospital or 
post discharge until 12 May 2020. For those patients 
discharged from hospital, primary care records were 
checked and any patients admitted to hospital with 
COVID-19 and discharged who had died in the commu-
nity within the censor period were noted. Those with an 
ongoing admission were censored on the study end date.
Statistics
Baseline characteristics
Baseline characteristics for the total population and 
ethnic communities are presented as mean (SD) or 
median (IQR) for continuous variables and as frequency 
(percentage) for categorical variables. Ethnic groups 









  Documented, n 736 483 137 53
  Mild, n (% of those recorded) 449 (61) 295 (61.1) 79 (57.7) 36 (67.9)
  Moderate, n (% of those recorded) 185 (25.1) 134 (27.7) 24 (17.5) 10 (18.9)
  Severe, n (% of those recorded) 102 (13.9) 54 (11.2) 34 (24.8) 7 (13.2)
Care escalation to ITU, n (%) 269 (12.1) 133 (8.6) 86 (21.0) 21 (15.7)
LOS in full days, median (IQR)
  LOS for total population 6 (2–12) 6 (2–12) 5 (2–9) 5 (3–11)
  LOS for patients discharged 5 (2–11) 6 (2–13) 4.5 (2–8) 5 (3–9)
  LOS for patients who died 6 (3–11) 6 (3–12) 5 (2–8) 6 (3–9)
Data are number (percentage) unless otherwise stated.
Ethnicity was self- reported or inferred (see the Methods section). Medical conditions were physician- confirmed and checked against 
admission and linked primary care notes. English Indices of Deprivation were calculated using postcode. Severity was determined by 
respiratory oxygen requirements (see the Methods section). Subgroup data are provided for those ethnicities which represented more than 
5% of the whole population.
For English Indices of Deprivation, the quintiles were as follows: quintile 1=33.5–78.1; quintile 2=21.7–33.2; quintile 3=14.4–21.5; quintile 
4=8.8–14.1; quintile 5=1.4–8.6.
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Standardised admission rate and standardised mortality rate by 
ethnicity
Ethnicity data for the Birmingham and Solihull area from 
the 2011 census were used to estimate expected numbers 
of admissions and deaths for each ethnic category condi-
tional on the observed numbers and sex- specific age 
distributions of COVID-19 admissions and deaths in 
UHB. The ratios of observed to expected numbers were 
calculated to provide standardised admission ratio (SAR) 
and standardised mortality ratio (SMR) for each ethnic 
category, and 95%, 99% and 99.9% CIs were obtained 
using the mid- p exact test.22
Predictors of mortality
The overall effects of age, sex, ethnicity, comorbidities 
and admission severity on mortality were tested by univari-
able analysis. The effect of ethnicity on mortality was then 
considered adjusting for age, sex, comorbidity counts 
and deprivation in a multivariable analysis. Cox model 
was used to derive adjusted HR (aHR) for mortality, 
defined as death from any cause after COVID-19. Survival 
time was calculated as the time between the collection 
of a sample on clinical suspicion to the date of death or 
study end date and was used for Kaplan- Meier estimates. 
Multiple parameterisations were tested for patient age, 
including linear fit, square- root transformation, cate-
gorical groupings and natural cubic splines. Categorical 
variables were fitted for sex, ethnicity, deprivation score 
quintiles and number of clinically assessed comorbid-
ities. The proportional hazards assumption was tested 
through correlation of the scaled Schoenfeld residuals 
with survival time, with hypothesis tests for independ-
ence.23 Models were then tested using propensity score 
matching,24 where age, sex, social deprivation index and 
comorbidities were matched and ethnicity was treated as 
a dichotomous variable. Models were fitted in R V.3.6.3 
using the survival package and twang package in ‘r’ ( www. 
r- project. org).25 All p values are reported exactly and no 
corrections were made for multiple comparisons unless 
stated.
Patient and public involvement
Three hundred and two patients and public members 
were consulted as to the use of health data to improve 
the care for people with acute, unplanned illness. A 
group of patients recovering from COVID-19 specifically 
were asked and supported the use of routinely collected 
health data to investigate the relationship between poor 
outcomes and ethnicity. A working group of staff and 
patients from black and Asian minority ethnic groups 
discussed the results and how they should be dissemi-
nated.
RESULTS
The study analysed 2217 consecutive patients admitted to 
UHB with a swab- proven diagnosis of COVID-19. A modi-
fied Consolidated Standards of Reporting Trials diagram 
(online supplementary figure S1) and a summary of 
the demographic and clinical characteristics on admis-
sion (table 1) are shown. Most patients (n=2132) had 
a Birmingham postcode. The majority of patients were 
male (1290 of 2217; 58.2%) and white (1540 of 2217; 
69.5%). High levels of comorbidity were identified across 
all ethnic groups (with 40.1% of patients having three or 
more comorbidities).
Of note, up to 50% had missing morbidity data and 
30% had missing ethnicity data using the secondary care 
records for the COVID-19- related admission alone, but 
>96% of ethnicity data and all available morbidity data 
were resolved through review of primary and secondary 
care records.
Comparison of baseline characteristics between ethnicities
South Asian patients, when compared with white patients, 
were younger (median age 61 years vs 77 years, p<0.001), 
had a higher prevalence of diabetes mellitus (48.1% 
vs 28.2%, p<0.001) but lower prevalence of dementia 
(5.4% vs 18.9%), chronic obstructive pulmonary disease 
(COPD) (4.9% vs 21.6%), atrial fibrillation (6.3% vs 
26.2%) and cerebrovascular disease (4.4% vs 15.1%) 
(p<0.0001 for all). Similar to the South Asian patients, 
black ethnic population were younger (median age 62 
years), had a higher prevalence of diabetes mellitus 
(53.7%) but lower prevalence of other key comorbidities 
than the white population. Two- thirds of the South Asian 
and black ethnicity came from the most deprived quin-
tile of deprivation compared with 36% from the white 
patients.
Across the course of data collection, the proportion 
of patients presenting from different ethnic groups 
was relatively stable (online supplementary figure S2), 
suggesting no differential transmission related to ethnic 
group within the location and timeframe studied.
SAR in different ethnicities
Age and sex SAR (95% CI) for South Asian women was 
74% higher (SAR 1.7, 95% CI 1.5 to 2.0) and for South 
Asian men 63% higher (SAR 1.6, 95% CI 1.4 to 1.9) 
than the standard population (see online supplementary 
table S1). In contrast white patients were less likely to be 
admitted in comparison with the standard population 
(white women: 0.8 (0.8–0.9); white men: 0.9 (0.8–0.9)). 
Admission rates were similar to expected rates of the 
standard population for black ethnicity.
Severity of COVID-19 at presentation in different ethnicities
In 736 patients admitted directly to the QEHB site, the 
severity of COVID-19 recorded on admission identified 
185 (25.1%) classified as moderate and 102 (13.9%) 
classified as severe. In this data set a higher propor-
tion of South Asians than whites were assessed to have 
severe disease on presentation (34 of 137 (24.8%) vs 54 
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Table 2 Comparison of demographics of patients who met the primary endpoint of death up to and including 12 May 2020
Patients currently 






receiving inpatient care 
and alive Patients who died
P value comparing 
all alive patients and 
patients who died
n 1448 1372 76 769
Age, IQR and range 68 (52–80) 68 (52–80) 66 (54–76) 80 (71–887) <0.001
Sex, n (%) (female) 637 (44.0) 616 (44.9) 21 (27.6) 290 (37.7) 0.004
Self- reported ethnicity, n (%) <0.001
  White 958 (66.2) 906 (66.0) 52 (68.4) 582 (75.7)
  Mixed/multiple 10 (0.7) 10 (0.7) 0 (0.0) 8 (1.0)
  South Asian/South Asian British 290 (20.0) 275 (20.0) 15 (19.7) 120 (15.6)
  Black/African/Caribbean/black British 94 (6.5) 92 (6.7) 2 (2.6) 40 (5.2)
  Other ethnic group 60 (4.1) 53 (3.9) 7 (9.2) 7 (0.9)
  Preferred not to say 16 (1.1) 16 (1.2) 0 (0.0) 6 (0.8)
  Unknown 20 (1.4) 20 (1.5) 0 (0.0) 6 (0.8)
Comorbidity count, n (%) <0.0001
  None 377 (26.0) 362 (26.4) 15 (19.7) 62 (8.1)
  1 or 2 593 (41.0) 555 (40.5) 38 (50.0) 295 (38.4)
  3 or more 478 (33.0) 455 (33.2) 23 (30.3) 412 (53.6)*
Morbidities
  Hypertension 490 (33.8) 457 (33.3) 33 (43.4) 374 (48.6) <0.001
  Cerebrovascular disease 128 (8.8) 125 (9.1) 3 (3.9) 140 (18.2) <0.001
  Atrial fibrillation 236 (16.3) 228 (16.6) 8 (10.5) 228 (29.6) <0.001
  Ischaemic heart disease, angina, myocardial 
infarct
286 (19.8) 276 (20.1) 10 (13.2) 260 (33.8) <0.001
  Diabetes (type 1 and 2) 459 (31.7) 431 (31.4) 28 (36.8) 293 (38.1) 0.002
  Asthma 296 (20.4) 280 (20.4) 16 (21.1) 143 (18.6) 0.299
  COPD 202 (14.0) 194 (14.1) 8 (10.5) 174 (22.6) <0.001
  Interstitial lung disease 24 (1.7) 23 (1.7) 1 (1.3) 25 (3.3) 0.015
  Chronic kidney disease 267 (18.4) 253 (18.4) 14 (18.4) 244 (31.7) <0.001
  Any active malignancy 87 (6.0) 84 (6.1) 3 (3.9) 65 (8.5) 0.030
  Dementia (all types) 131 (9.0) 129 (9.4) 2 (2.6) 195 (25.4) <0.001
  Obesity 176 (12.2) 163 (11.9) 13 (17.1) 91 (11.8) 0.825
English Indices of Deprivation, n (%) 0.848
  1 667 (46.1) 633 (46.1) 34 (44.7) 336 (43.7)
  2 271 (18.7) 253 (18.4) 18 (23.7) 145 (18.9)
  3 200 (13.8) 191 (13.9) 9 (11.8) 111 (14.4)
  4 150 (10.4) 146 (10.6) 4 (5.3) 80 (10.4)
  5 139 (9.6) 128 (9.3) 11 (14.5) 86 (11.2)
  Missing 21 (1.5) 21 (1.5) 0 (0.0) 11 (1.4)
Duration of symptoms prior to admission (in 
days), n where data were available (%)
245 (16.9) 223 (16.3) 22 (28.9) 110 (14.3)
Median (IQR) 9 (2–16) 9 (3–16) 7 (5–12) 7 (3–15)
Severity of COVID-19 on admission, n (%) n=489 n=453 n=36 n=247 <0.001
  Mild 348 (71.2) 338 (74.6) 10 (27.8) 101 (40.8)
  Moderate 91 (18.6) 81 (17.8) 10 (27.8) 94 (38.1)
  Severe 50 (10.2) 34 (7.5) 16 44.4) 52 (21.1)†
Data are number (percentage) unless otherwise stated.
Medical conditions were self- reported and checked against admission and linked primary care notes.
Groups are compared using χ2 analysis, except for pregnancy where Fisher’s exact test was used, and age distribution where Kruskal- Wallis was used.
Of note, p values compared all patients currently alive (in patients or discharged) versus those who had died.
For English Indices of Deprivation, the quintiles were as follows: quintile 1=33.5–78.1; quintile 2=21.7–33.2; quintile 3=14.4–21.5; quintile 4=8.8–14.1; quintile 5=1.4–8.6.
*Increased deaths with 3 or more (p<0.0001) comorbidities on post- hoc analysis.
†Increased deaths in moderate and severe cases versus mild cases on post- hoc analysis (p<0.0001) for comparisons with patients discharged alive and currently alive.
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S2. A higher proportion of South Asians than whites 
were admitted to intensive care unit (86 of 410 (21.0%) 
vs 133 of 1540 (8.6%), p<0.001). There were no differ-
ences in the duration of symptoms prior to admission by 
ethnic group (median: South Asian=7 days, white=6 days, 
black=7 days, p=0.40).
Characteristics of patients who died
On 12 May 2020, 769 of 2217 (34.6%) patients had 
died in hospital or following discharge. These patients 
were older, more likely to be male, white, have multiple 
comorbidities, and in the 736 patients admitted directly 
to the QEHB site, in whom data were available, more 
likely to have moderate or severe disease on admission, 
in comparison with all other groups of patients (table 2).
In those in whom data were available, people who died 
had a shorter duration of symptoms prior to admission 
compared with those who were still alive (median 7 days 
(3–36) vs 9 (5–36) days). In all in whom data were avail-
able, the duration of symptoms prior to admission did 
not relate to disease severity on admission (p=0.46). The 
relationships between survival from diagnosis and age, 
gender and number of comorbidities are further illus-
trated in figure 1.
Ethnic group outcome analysis
SMR between different ethnic groups
In comparison with the expected number of deaths based 
on Birmingham and Solihull 2011 census data age and 
sex structure, there were significantly more South Asian 
women and men who died with a positive COVID-19 
swab than would be expected: SMR (95% CI): Asian 
women 1.9 (1.4 to 2.6) and Asian men 1.7 (1.4 to 2.1). In 
contrast fewer white women and men died than would be 
expected: SMR (95% CI): white women 0.9 (0.8 to 1.0) 
and white men 0.9 (0.8 to 1.0) (see online supplementary 
table S1). For those of black ethnicity, death rates were 
not different from the expected rates in the standard 
population.
Survival curves for mortality in different ethnicities
An age- adjusted Kaplan- Meier showed that although 
there were no differences in age- adjusted survival in 
white and black ethnicities, patients from Asian ethnic 
groups were less likely to survive (see figure 2).
Multivariable analysis
In a multivariable Cox regression model adjusted for age, 
sex, comorbidity counts and deprivation, South Asian 
ethnicity (aHR 1.4, 95% CI 1.2 to 1.8) was associated with 
Figure 1 Kaplan- Meier estimates of survival for COVID-19- positive patients. Data compared survival status of patients by 
age (A, p<0.001), sex (B, p<0.001) and simple comorbidity counts as listed in table 1 (C, p<0.001). Comparison done using 
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a significantly higher risk of death. Within the limits of 
the power of the study, there was absence of a significant 
difference in survival for black ethnicity compared with 
the white population (aHR 1.1, 95% CI 0.8 to 1.5). In 
addition to this we found age z- score (aHR 2.4, 95% CI 
1.8 to 3.2) and comorbidities (1–2 comorbidities, aHR 
1.7, 95% CI 1.3 to 2.2; 3 or more comorbidities, aHR 2.3, 
95% CI 1.7 to 3.0) as significant predictors. We also found 
a significant effect of sex (aHR for male sex, 1.3, 95% 
CI 1.1 to 1.5), with the interaction between age and sex 
suggesting an amplified risk in men with increasing age 
(table 3). The main effects of age and multiple comorbid-
ities were modified by an interaction (aHR for age inter-
action with 1–2 comorbidities, 0.9, 95% CI 0.7 to 1.2; age 
interaction with 3+ comorbidities, 0.7, 95% CI 0.5 to 0.9) 
that attenuated the relative impact of increasing comor-
bidity at advanced age. Of note, the HR of 1.4 (1.2–1.8) 
did not change (1.4, 1.2–1.8) if the interactions were 
removed from the model.
To further test the assumption that South Asian 
ethnicity was associated with worse outcomes even when 
comorbidities, age and sex were considered, propensity 
score matching was conducted, matching for the same 
factors in the Cox regression but categorising ethnicity 
into South Asian or not. With propensity score matching 
the HR for risk of death was 1.3 (1.0–1.6) for South Asian 
patients compared with non- South Asian patients. When 
comorbidities were added independently (rather than as 
a count) using propensity score matching, South Asian 
ethnicity was still associated with a significantly higher 
risk of death (HR 1.4, 95% CI 1.1 to 1.7).
DISCUSSION
This is the first study to specifically describe the impact of 
South Asian ethnicity on the outcome of COVID-19 infec-
tion using highly characterised and accurate primary 
and secondary data from patients admitted to hospital 
in the UK. South Asians were significantly younger and 
twice likely to have diabetes than white patients, and 
when accounted for the age structure of the local popu-
lation had a high admission and death rate. South Asians 
Figure 2 Age- adjusted Kaplan- Meier estimates of survival for different ethnic groups of COVID-19- positive patients. 
Data compared age- adjusted survival status of patients by ethnicity (p<0.001 using the age ranges as listed in figure 1A). 
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were also more likely to present with severe symptoms, 
but with no difference in the duration of symptoms and 
more likely to be admitted to ITU. Importantly, after 
adjusting for age, deprivation and multiple comorbidi-
ties, the effect of South Asian ethnicity on mortality was 
42% higher.
Our study is in line with two population- based 
studies10 11 where South Asians were found to be at 
increased risk of death, with similar effect size with the 
study11 that considered similar covariates for adjusting 
(aHR 1.4 (1.2–1.8) vs 1.6 (1.4–1.8)). However, the find-
ings of the two population- based studies could reflect 
infection rates rather than case fatality rates, and there-
fore differentiating this is important from a public health 
and research perspective. If increased deaths in South 
Asian patients reflected high infection rates, then our 
focus should be on looking at barriers and emphasising 
the need for adherence to current social distancing 
guidelines. If this reflects an increased susceptibility to 
poorer outcomes from SARS- CoV-2 infection, we need to 
urgently understand the reasons for severity of infection 
and mitigate risk or develop targeted treatments. While 
no firm conclusion can be drawn from the current data 
set, our study potentially supports the latter, with South 
Asian patients more likely to be admitted, more likely 
to present with severe symptoms and have an increased 
risk of mortality. This supports the call by the govern-
ment and research community for urgent research on 
the reasons underpinning these observations. Our study 
was not sufficiently powered to report on other ethnic 
groups, particularly those of black ethnicity, and there-
fore the findings among these ethnic groups should be 
interpreted cautiously.
The excess age- adjusted mortality in COVID-19 is not 
solely attributable to a range of cardiovascular and meta-
bolic risk factors that are over- represented in this ethnic 
group. In sensitivity analysis the HR for South Asian 
ethnicity using both Cox regression and propensity score 
matching was stable when ‘number of co- morbidities’ 
was exchanged for the presence of specific comorbidities 
including diabetes mellitus and hypertension. To place 
this in context, the effect of South Asian on mortality is 
significantly less than the effect of one or more comor-
bidities (present in 80.2% of all admitted patients) and 
approximates to the effect of ageing 10 years in the 
white population. In this study we did not observe an 
independent signal related to higher deprivation levels26 
and poor outcomes in contrast to the population- based 
study,11 suggesting deprivation is likely to be related to 
high infection rates and thereby high mortality, rather 
than high rates of severe infection leading to increased 
mortality.
It is notable that in the subanalysis of patients admitted 
to QEHB, where we were able to immediately integrate a 
COVID-19- specific assessment into our EHR, South Asian 
patients appear to present with more severe disease, but 
there was no difference in the duration of symptoms 
prior to admission, suggesting disease severity was not 
caused simply by delayed presentation to medical services 
or differences in health service utilisation (although this 
cannot be fully excluded, given the unknown burden of 
COVID-19 in the community). Indeed, when comparing 
those still alive and those who had died at the end of the 
study, the patients who had died had a shorter history 
of symptoms prior to admission, suggesting a different 
disease course.
A significantly higher rate of admission to ITU in the 
South Asian ethnic group could relate to this more severe 
disease at presentation. It may also relate to patient- level 
differences in joint decision- making regarding ITU 
treatment, in patients who have higher levels of specific 
comorbidities such as dementia and COPD, groups that 
are significantly over- represented in the white ethnic 
group, which was also significantly older.
The limitations in our overall analysis need to be consid-
ered, specifically that 5% of patients remain in hospital at 
the time of the data lock and more patients have been 
admitted, so our findings will evolve. Since the propor-
tion of patients presenting from different ethnic groups 
Table 3 Adjusted HR of risk factors for mortality
Predictors Estimates CI P value
Age (z- score) 2.4 1.8 to 3.2 <0.001
White Reference
Asian 1.4 1.2 to 1.8 0.001
Black 1.1 0.8 to 1.5 0.536
Mixed 1.9 0.9 to 3.9 0.072
Unknown 0.8 0.4 to 1.9 0.676
Other 0.6 0.3 to 1.3 0.226
Not stated 1.2 0.6 to 2.8 0.603
Female Reference
Male 1.3 1.1 to 1.5 0.014
Deprivation quintile 1 Reference
Deprivation quintile 2 0.9 0.7 to 1.0 0.126
Deprivation quintile 3 0.9 0.7 to 1.1 0.439
Deprivation quintile 4 0.8 0.7 to 1.1 0.183
Deprivation quintile 5 0.9 0.7 to 1.2 0.593
Deprivation quintile 
missing
1.0 0.5 to 1.8 0.930
No comorbidity Reference
Comorbidity group 1–2 1.7 1.3 to 2.2 <0.001
Comorbidity group 3+ 2.3 1.7 to 3.0 <0.001
Age (z- score) × sex (male) 1.2 1.0 to 1.5 0.055
Age (z- score) × 
comorbidity group 1–2
0.9 0.7 to 1.2 0.529
Age (z- score) × 
comorbidity group 3+
0.7 0.5 to 0.9 0.015
Multivariable Cox regression model including age (z- score), 
ethnicity, sex and comorbidity count as covariates.
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was stable across the course of data collection, any conse-
quence for our main conclusion on the mortality risk in 
South Asians admitted to hospital is likely to be small. 
Data on the admission severity scoring did not include 
all patients, which is a limitation. This limitation reflects 
the real- world response within a global pandemic which 
includes designing a score to inform care escalation deci-
sions and updating the UHB electronic health record to 
capture this information during the first wave of patient 
admissions. However, these data suggest further explora-
tion of severity of disease at presentation is warranted.
It is also important to acknowledge that standardised 
admission and mortality ratios from Birmingham and 
Solihull use the most recent census data, but that these 
are from 2011. Estimates of the contemporary age struc-
ture do not however suggest a need to significantly qualify 
these findings. The UK has not undertaken widespread 
screening or diagnosis of patients in the community, and 
we are therefore unable to comment on the natural history 
of COVID-19 prior to admission to secondary care, irre-
spective of ethnic group. This testing regimen is likely to 
evolve with the development of capacity and methodology 
and will provide a more complete picture of COVID-19. 
A description of disease in the community will help build 
a clearer understanding of the apparent excess mortality 
following admission, for which there remain a number 
of possible explanations. A limitation of this study (and, 
arguably, of any observational study) is that it cannot 
exclude the possibility that another, unmeasured variable 
could account for the ethnicity effect described here. The 
assessment of comorbidities does not reflect the degree of 
severity of the condition, nor disease treatment or control, 
and the assessment of social deprivation might impact on 
chronic disorders. There is also the possibility that differ-
ences in work or home living arrangements might impact 
on potential transmission and this may be different across 
ethnic communities. However, a real strength has been 
the ability to study a highly curated and complete data set, 
without the inherent issues of significant undercoding seen 
with morbidity and ethnicity data when using a secondary 
care data set.
The biological basis of any difference in outcome can 
only be speculated on at present. There are reported 
differences in outcomes for non- white ethnic groups from 
ARDS even after adjusting for sex, age, disease severity, type 
of hospital and median household income.27 28 The worst 
clinical manifestations of COVID-19 appear to be associ-
ated with a cytokine storm syndrome. Here a hypercyto-
kinaemia is seen,4 with predictors of mortality reflecting a 
virally induced inflammatory state which can be assessed 
using a scoring system including validated clinical labora-
tory tests.29 Candidate genes associated with ARDS have 
been identified in bioinformatic analyses, with a strong 
predominance of inflammatory pathways, including reac-
tive oxygen species, innate immunity- related inflammation 
and endothelial vascular signalling pathways.30 Ethnicity 
may influence cytokine gene polymorphisms and inflam-
matory profiles following specific challenges,31 with some 
ethnic groups more prone to a heightened inflamma-
tory response. Of note, socioeconomic factors might also 
impact on inflammatory pathways and gene expression.32 
These factors remain poorly understood, and were a 
priority for our patient and public involvement group who 
were consulted for this study, and there is an urgent need 
to understand the genomic and associated phenomic and 
socioeconomic characteristics of patients who are suscep-
tible or resistant to the severe manifestations of COVID-19 
to understand this further.
Although our study includes only one NHS Founda-
tion Trust, it covers an ethnically diverse contiguous 
population of 1.3 million people for which it is the 
sole provider of adult acute secondary care across four 
hospital sites. This provides for continuity of data, clin-
ical protocols and access to therapy. The immediate 
availability of access to an electronic representation of 
a primary care record to support the care of admitted 
patients also supports the integrity of data collection, 
the quality of which might otherwise be more limited.33
Our findings, which describe and quantify the risk of 
COVID-19 in the South Asian population, are relevant 
to national policy and to understanding the under-
lying biological mechanisms in ‘at risk’ populations. 
Future studies will extend our observations and explore 
underlying epidemiology and biological mechanisms, 
to improve interventions based in the community, the 
emergency department, ward and ITU. Perhaps most 
importantly our findings inform the UK’s national 
discussion on at ‘at risk’ groups and the ensuing fear 
arising from uncertainty.
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